Industry n/a · SIC —
Jasper Therapeutics, Inc.
JSPRW
Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Community sentiment
Where do you think JSPRW is heading?
1 month
6 months
12 months
5 years
Keep private notes on JSPRW — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
JSPRW vs S&P 500 · rebased to 100
▼ -60.0% / yr▼ 69.2 pts / yr vs S&P 500(S&P 500 +9.3% / yr)▼ 98.6% total
Compare:
Early cycleMid cycleLate cycleRecession
Background shading marks the US business-cycle phase at each point in time — early, mid and late expansion, then recession— so you can see which economic backdrop each move happened in. Recessions are NBER-official; expansion sub-phases are ActaClear's editorial dating.
Lines:
Overlay:
Live market
as of Jun 29, 2026$0.02
▲ 34.48%
- Market cap
- $436.8K
- Enterprise value
- $436.8K
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $0.15
- 52-wk low
- $0.01
- Beta
- —
- Shares out
- 28.0M
What this company does
Not yet available for JSPRW.
Key risks
Not yet available for JSPRW.
ActaClear Score
Not enough peer data in this industry to rank yet. The score will appear once we have at least a handful of comparable companies on the same page.